Back to Search
YVETTE KASAMON, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1578510756Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
D58879(MD)
Research & Publications (20)
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning.
PMID 19167684·Biol Blood Marrow Transplant·2009
3-trial
FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma.
PMID 18300772·Curr Opin Oncol·2008
6-review
Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
PMID 17204717·J Nucl Med·2007
6-review
Management of symptomatic, untreated chronic lymphocytic leukemia.
PMID 17097783·Blood Rev·2007
6-review
Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia.
PMID 16322303·Clin Cancer Res·2005
3-trial
AIDS-related primary central nervous system lymphoma.
PMID 16083829·Hematol Oncol Clin North Am·2005
6-review
High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.
PMID 15682069·Biol Blood Marrow Transplant·2005
8-other
Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma.
PMID 15625543·Biol Blood Marrow Transplant·2005
8-other
Treatment advances in adult Burkitt lymphoma and leukemia.
PMID 15314510·Curr Opin Oncol·2004
6-review
FDG PET and high-dose therapy for aggressive lymphomas: toward a risk-adapted strategy.
PMID 15075899·Curr Opin Oncol·2004
6-review
From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.
PMID 19403881·J Nucl Med·2009
6-review
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen.
PMID 18978825·Bone Marrow Transplant·2009
8-other
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder.
PMID 18645482·Transplantation·2008
3-trial
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
PMID 17889355·Biol Blood Marrow Transplant·2007
2-rct
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma.
PMID 12631591·Clin Cancer Res·2003
8-other
EBV-associated lymphoma and chronic inflammatory demyelinating polyneuropathy in an adult without overt immunodeficiency.
PMID 11921025·Am J Hematol·2002
5-case
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
PMID 11742496·Br J Cancer·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 N WOLFE ST
BALTIMORE, MD 21287 - Phone
- (410) 955-8964
Quick Facts
- NPI
- 1578510756
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile